Changes in accounting estimates based on the assumption of a prolonged COVID-19 pandemic
First written in FY2021-Q2. 4 of 5 entries say "Restated". Latest entry: FY2022-Q3.
The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.
- FY2022-Q3RestatedAnnual report
「The Group makes accounting estimates, including the valuation of inventories and shares and other securities and impairment testing of goodwill, based on the assumption that the effects of COVID-19 will continue through the end of the current consolidated fiscal year. There have been no material changes from the disclosures in the securities report for the previous consolidated fiscal year.」
The company continues to make accounting estimates based on the assumption that the effects of the infection will continue through the end of the current consolidated fiscal year, and states that there have been no material changes from the disclosures for the previous fiscal year. - FY2022-Q2RestatedAnnual report
「The Group makes accounting estimates, including the valuation of inventories and shares and other securities and impairment testing of goodwill, based on the assumption that the effects of COVID-19 will continue through the end of the current consolidated fiscal year. There have been no material changes from the disclosures in the securities report for the previous consolidated fiscal year.」
The company continues to make accounting estimates based on the assumption that the effects of the infection will continue through the end of the current consolidated fiscal year, and states that there have been no material changes from the disclosures for the previous fiscal year. - FY2022-Q1RestatedAnnual report
「The Group makes accounting estimates, including the valuation of inventories and shares and other securities and impairment testing of goodwill, based on the assumption that the effects of COVID-19 will continue through the end of the current consolidated fiscal year. There have been no material changes from the disclosures in the securities report for the previous consolidated fiscal year.」
The company continues to make accounting estimates based on the assumption that the effects of the infection will continue through the end of the current consolidated fiscal year, and states that there have been no material changes from the disclosures for the previous consolidated fiscal year. - FY2021-Q3RestatedAnnual report
「Because the timing of containment of the spread of COVID-19 remained uncertain worldwide, including in Japan, the Group made accounting estimates, including the valuation of inventories and impairment testing of investments and goodwill, based on the assumption that the effects would continue through the end of the current consolidated fiscal year.」
The company continues to make accounting estimates based on the assumption that the effects of COVID-19 will continue through the end of the current consolidated fiscal year, and states that there were no material changes in the third quarter accounting period. - FY2021-Q2WorsenedAnnual report
「At the end of the previous consolidated fiscal year, the Group had made accounting estimates, including the valuation of inventories and impairment testing of investments and goodwill, based on the assumption that the spread of COVID-19 would subside by around the first half of the year. However, because the timing of containment remained uncertain worldwide, including in Japan, during the six-month period of the current consolidated fiscal year, the Group made accounting estimates based on the assumption that the effects would continue through the end of the current consolidated fiscal year.」
The company changed its assumption from the infection subsiding by around the first half of the year to its effects continuing through the end of the current consolidated fiscal year, and reflected this in accounting estimates including inventory valuation and impairment testing of investments and goodwill.